SAN FRANCISCO, July 31, 2026 /PRNewswire/ -- Hagens Berman alerts investors in ADMA Biologics, Inc. (NASDAQ: ADMA) that a securities fraud class action lawsuit has been filed. The lawsuit focuses on alleged misrepresentations concerning the company's financial condition, revenue...
Hence then, the article about adma august 10 2026 deadline adma biologics inc investors have opportunity to lead class action lawsuit hbss was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( ADMA AUGUST 10, 2026 DEADLINE: ADMA Biologics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit- HBSS )
Also on site :
- Kenya confirms first Ebola case after patient dies
- Taylor Swift Shatters All-Time Billboard Record as ‘Patient Zero’ Leads 4 New Songs Into Global Top 10
- Croatia Face Spain Today: Kickoff Time and Broadcast Details